STORM Therapeutics
Latest round
- Series C
Last raised
- Nov 2026
Total raised
- $185M
Investors
- 11
About STORM Therapeutics
STORM Therapeutics Limited is engaged in the development of RNA modifying enzyme therapies. The company, headquartered in England, UK, was co-founded by Tony Kouzarides and Eric Miska. STORM Therapeutics specializes in developing small molecule therapies targeting RNA modifying enzymes (RMEs) for oncology and other diseases.90, operating through partnerships and collaborations in the biotechnology and pharmaceutical sectors to generate income from co-development agreements and licensing of proprietary therapies.
Who invested in STORM Therapeutics
11 investors across 7 rounds
See all investors in STORM Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Nov 3, 2026
Amount
$56M
Investors
Series C
Apr 5, 2026
Amount
$56M
Investors
Series B
May 27, 2022
Amount
$33M
Investors
Series A
May 24, 2019
Amount
$18M
Investors
Series A
Jul 17, 2018
Amount
$7M
Investors
Series A
Jun 15, 2016
Amount
$16M
Investors
Seed
May 1, 2015
Amount
Undisclosed
Investors
Questions about STORM Therapeutics
Who invested in STORM Therapeutics?
STORM Therapeutics has 11 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has STORM Therapeutics raised?
STORM Therapeutics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did STORM Therapeutics last raise money?
STORM Therapeutics's most recent round on record is a Series C, in Nov 2026.
What does STORM Therapeutics do?
STORM Therapeutics Limited is engaged in the development of RNA modifying enzyme therapies.
Where is STORM Therapeutics headquartered?
STORM Therapeutics is headquartered in Cambridge, UK.
Which VCs invest in companies like STORM Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at STORM Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like STORM Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.